日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes

帕博利珠单抗联合紫杉醇治疗 HR+/HER2- 乳腺癌患者,包括 HER2 富集型或基底样亚型

Conte, Benedetta; Brasó-Maristany, Fara; Pascual, Tomás; Hernando, Cristina; Vázquez, Silvia; Blanch, Salvador; Oliveira, Mafalda; Virizuela, Juan Antonio; Muñoz, Montserrat; Seguí, Elia; Rodriguez-Hernandez, Adela; Vidal Losada, Maria Jesus; Galván, Patricia; Castillo, Oleguer; Blasco, Paula; Alva, Manuel; Chic, Nuria; Sanfeliu, Esther; Cano-Crespo, Sara; Salvador, Fernando; Villacampa, Guillermo; Villanueva, Lorea; Ferrero-Cafiero, Juan Manuel; Vivancos, Ana; Prat, Aleix; Ciruelos, Eva

Immune checkpoint inhibition in Epstein-Barr virus associated gastric cancer: a case report highlighting the role of biomarker-driven treatment selection

免疫检查点抑制剂在EB病毒相关胃癌中的应用:一例强调生物标志物驱动治疗选择作用的病例报告

Yaringaño, Jesús; Blázquez-López, Andrea; Acosta, Daniel; Landolfi, Stefania; Castro-Boix, Sandra; Aguilar, Susana; Vivancos, Ana; Élez, Elena; Terán-Brage, Eduardo

Case Report: Lorlatinib for the treatment of ALK-rearranged poorly differentiated thyroid carcinoma after progression to prior ALK-specific tyrosine-kinase inhibitor

病例报告:劳拉替尼用于治疗既往接受过ALK特异性酪氨酸激酶抑制剂治疗后进展的ALK重排低分化甲状腺癌

Yaringaño, Jesús; Hernando, Jorge; García-Álvarez, Alejandro; Iglesias-Felip, Carmela; Zafón, Carles; Vivancos, Ana; Roca-Herrera, María; Pérez-Fernández, Sergio; Martínez-Badal, Sandra; Elguero, Belén; Capdevila, Jaume

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX 在老年 HER2 阳性早期乳腺癌患者中的应用:曲妥珠单抗±化疗 RESPECT 试验的长期随访结果

Nozawa, Kazuki; Sawaki, Masataka; Uemura, Yukari; Tsuneizumi, Michiko; Takano, Toshimi; Gondo, Naomi; Hara, Fumikata; Harao, Michiko; Toyama, Tatsuya; Taira, Naruto; Vivancos, Ana; Perou, Charles M; Sanfeliu, Esther; Brasó-Maristany, Fara; Parker, Joel S; Buckingham, Wesley; Paré, Laia; Villacampa, Guillermo; Marín-Aguilera, Mercedes; Villagrasa, Patricia; Prat, Aleix; Iwata, Hiroji

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study

一项针对可切除胃癌或胃食管交界处癌患者的围手术期阿维鲁单抗联合化疗的II期研究——MONEO研究

Alsina, Maria; Villacampa, Guillermo; de Andrea, Carlos; Vivancos, Ana; Ponz-Sarvise, Mariano; Arrazubi, Virginia; Jimenez-Fonseca, Paula; Diez, Marc; Sanz-Garcia, Enrique; Martínez, Eva; Guardeño, Raquel; Calvo, Mariona; Bugés, Cristina; Longo, Federico; Navarro, Víctor; García-Galea, Eduardo; Gros, Alena; Ochoa, Maria C; Lopez-Janeiro, Alvaro; Sanchez-Gregorio, Sandra; Herrero, Claudia; Labiano, Ibone; Vila-Casadesús, Maria; López, Dario; Alexandru, Raluca; Muñoz, Susana; Tabernero, Josep; Melero, Ignacio

Identifying germline pathogenic variants in breast cancer using tumor sequencing

利用肿瘤测序技术鉴定乳腺癌中的种系致病变异

Cruellas, Mara; Papakonstantinou, Andri; López-Fernández, Adrià; Castillo, Ester; Matito, Judit; Gómez, Marina; Rezqallah, Alejandra; Vega, Sharela; Navarro, Víctor; Torres, Maite; Moles-Fernández, Alejandro; Saura, Cristina; Vivancos, Ana; Balmaña, Judith; Oliveira, Mafalda

Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies

优化早期免疫疗法试验:生物标志物富集策略的作用

Catani, Greta; Morchón-Araujo, Daniel; Mirallas, Oriol; Sánchez-Pérez, Vicky; Nuciforo, Paolo; Villacampa, Guillermo; Dienstmann, Rodrigo; Vivancos, Ana; Garralda, Elena; Hernando-Calvo, Alberto

Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression

对欧洲和拉丁美洲人群胃癌的全面组织病理学分析揭示了PD-L1、HER2、p53和MUC6表达的差异。

Martínez-Ciarpaglini, Carolina; Barros, Rita; Caballero, Carmelo; Boggino, Hugo; Alarcón-Molero, Lorena; Peleteiro, Bárbara; Ruiz-García, Erika; Fernandez-Figueroa, Edith; Herrera-Goepfert, Roberto; Díaz-Romero, Consuelo; Ferreira, Rui; Groen-van Schooten, Tessa S; Gauna, Cinthia; Pereira, Rita; Cantero, Daniel; Lezcano, Horacio; Esteso, Federico; O Connor, Juan; Riquelme, Arnoldo; Owen, Gareth I; Garrido, Marcelo; Roa, Juan Carlos; Ruiz-Pace, Fiorella; Vivancos, Ana; Diez-García, Marc; Alsina, Maria; Matito, Judit; Martin, Agatha; Gómez, Marina; Castillo, Ester; Vila, Maria; Santos-Antunes, João; Costa, Andreia; Lordick, Florian; Farrés, Judith; Palomar-De Lucas, Brenda; Cabeza-Segura, Manuel; Villagrasa, Rosanna; Jimenez-Martí, Elena; Miralles-Marco, Ana; Dienstmann, Rodrigo; Derks, Sarah; Figueiredo, Ceu; Cervantes, Andrés; Carneiro, Fátima; Fleitas-Kanonnikoff, Tania

Expanding screening through the use of liquid biopsy for early cancer detection

利用液体活检扩大筛查范围,以早期发现癌症

Perachino, Marta; Ortiz, Carolina; Carmona, Javier; Saura, Cristina; Vivancos, Ana

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response

Patritumab deruxtecan治疗HER2阴性乳腺癌:SOLTI-1805 TOT-HER3机会窗口试验的B部分结果及早期反应的生物学决定因素

Brasó-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martínez-Sáez, Olga; Cejalvo, Juan Miguel; Margelí, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; González-Farré, Blanca; Sanfeliu, Esther; Òdena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana María; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sánchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martín; Izarzugaza, Yann; Galván, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomás; Prat, Aleix; Oliveira, Mafalda